Inflammatory rheumatologic disorders in the elderly

References

• McGann PE. Geriatric assessment for the rheumatologist. Rheum Dis Clin North Am 2000; 26(3): 415–32
   PubMedGoogle Scholar
• Yung RL. Changes in immune function with age. Rheum Dis Clin North Am 2000; 26(3): 455–73
   PubMedGoogle Scholar
• Percy LA, Fang MA. Geropharmacology for the rheumatologist. Rheum Dis Clin North Am 2000; 26(3): 433–54
   PubMedGoogle Scholar
• Winjands MJ, van Riel PL, Gribnau FW, et al. Risk factors of second-line antirheumatic drugs in rheumatoid arthritis. Semin Arthritis Rheum 1990; 19(6): 337–52
   PubMedGoogle Scholar
• O'Callaghan JW, Brooks PM. Disease-modifying agents and immunosuppressive drugs in the elderly. Clin Rheum Dis 1986; 12(1): 275–89
   PubMedGoogle Scholar
• Evans JM, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 2000; 26(3): 493–515
   PubMed Web of Science ®Google Scholar
• Salvarani C, Gabriel SE, O'Fallon WM, et al. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970–1991. Arthritis Rheum 1995; 38(3): 369–73
   PubMedGoogle Scholar
• Chuang TY, Hunder GG, Ilstrup DM, et al. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97(5): 672–80
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001; 30(4): 249–56
   PubMed Web of Science ®Google Scholar
• Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000; 18(4 Suppl 20): S43–8
   Google Scholar
• Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997; 337(19): 1336–42
   PubMed Web of Science ®Google Scholar
• Barrier J, Potei G, Renaut-Hovasse H, et al. The use of Doppler flow studies in the diagnosis of giant cell arteritis: selection of temporal artery biopsy site is facilitated. JAMA 1982; 248(17): 2158–9
   PubMedGoogle Scholar
• Evans JM, Bowles CA, Bjornsson J, et al. Thoracic aortic aneurysm and rupture in giant cell arteritis: a descriptive study of 41 cases. Arthritis Rheum 1994; 37 (10): 1539–47
   PubMedGoogle Scholar
• Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998; 41 (8): 1497–504
   PubMed Web of Science ®Google Scholar
• Font C, Cid MC, Coll-Vincent B, et al. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997; 36(2): 251–4
   PubMedGoogle Scholar
• Gordon LK, Levin LA. Visual loss in giant cell arteritis. JAMA 1998; 280 (4): 385–6
   PubMedGoogle Scholar
• Yazici Y, Paget SA. Elderly-onset rheumatoid arthritis. Rheum Dis Clin North Am 2000; 26(3): 517–26
   PubMed Web of Science ®Google Scholar
• van Schaardenburg D, Breedveld FC. Elderly-onset rheumatoid arthritis. Semin Arthritis Rheum 1994; 23(6): 367–78
   PubMed Web of Science ®Google Scholar
• Kammer GM, Mishra N. Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am 2000; 26(3): 475–92
   PubMedGoogle Scholar
• Font J, Pallares L, Cervera R, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991; 50(10): 702–5
   PubMed Web of Science ®Google Scholar
• Manoussakis MN, Tzioufas AG, Silis MP, et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69(3): 557–65
   PubMed Web of Science ®Google Scholar
• Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72(2): 113–24
   PubMed Web of Science ®Google Scholar
• Hahn BH. Management of systemic lupus erythematosus. In: Ruddy S, Harris ED, Sledge CB, et al, eds. Kelley's textbook of rheumatology. 6th ed. Philadelphia: WB Saunders, 2001: 1125–44
   Google Scholar
• Agudelo CA, Wise CM. Crystal-associated arthritis in the elderly. Rheum Dis Clin North Am 2000; 26(3): 527–46
   PubMedGoogle Scholar
• Wortmann RL, Kelley WN. Gout and hyperuricemia. In: Ruddy et al, eds, 23 pp 1339–76
   Google Scholar
• Puig JG, Michan AD, Jimenez ML, et al. Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 1991; 151(4): 726–32
   PubMedGoogle Scholar
• Scott JT, Higgens CS. Diuretic induced gout: a multifactorial condition. Ann Rheum Dis 1992; 51(2): 259–61
   PubMedGoogle Scholar
• Reginato AJ, Reginato AM. Diseases associated with deposition of calcium pyrophosphate or hydroxyapatite. In: Ruddy et al, eds,” pp 1377–90
   Google Scholar
• Sanmarti R, Panella D, Brancos MA, et al. Prevalence of articular chon- drocalcinosis in elderly subjects in a rural area of Catalonia. Ann Rheum Dis 1993; 52(6): 418–22
   PubMedGoogle Scholar
• O'Rourke KS. Myopathies in the elderly. Rheum Dis Clin North Am 2000; 26(3): 647–72
   PubMedGoogle Scholar
• Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. CurrOpin Rheumatol 1998; 10(6): 530–42
   PubMedGoogle Scholar
• Buchbinder R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study. Ann. Intern Med 2001; 134(12): 1087–95
   Google Scholar
• Marie I, Hatron P-Y, Levesque H, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 1999; 78(3): 139–47
   PubMed Web of Science ®Google Scholar
• Yazici Y, Kagen LJ. The association of malignancy with myositis. Curr Opin Rheumatol 2000; 12(6): 498–500
   PubMed Web of Science ®Google Scholar
• Beihorn LR, Hess EV. Erosive osteoarthritis. Semin Arthritis Rheum 1993; 22(5): 298–306
   PubMedGoogle Scholar